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Available online 12 January 2016Introduction: In this retrospective study concerning patients with Parkinson's disease (PD) scanned with 18-F-
Dopa PET (N=129), we looked for an association between reduced 18-F-Dopa uptake and the key PD symptoms
tremor and hypokinesia-rigidity. We hypothesized to ﬁnd a stronger correlation between dopaminergic deple-
tion in the striatum and hypokinesia-rigidity compared to tremor.
Methods: The onset side of symptoms (documented for 102 patients) as well as the ﬁrst registered UPDRS
(available for 79 patients) was used to correlate with F-Dopa uptake values in the caudate nucleus and putamen
in this large retrospective sample.
Results: Reduced F-Dopa uptake was contralateral to hypokinesia-rigidity symptoms and correlated with its se-
verity (quantiﬁed by UPDRS). For tremor severity, no correlation was seen with F-Dopa reduction. Furthermore,
freezing of gait correlated with reduced F-Dopa uptake in the putamen of the right hemisphere.
Conclusion and discussion: Our results, obtained in a large patient group, provides support for the concept that
tremor in PD is not only based on a dopamine related pathway but may rely on a different pathway.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Parkinson's disease (PD) is characterized by asymmetrical neuronal
loss in the substantia nigra, which results in striatal dopamine depletion
and contralateral symptoms. Dopamine depletion can be assessed
in vivo by Position Emission Tomography (PET) using the tracer L-3,4-
Dihydroxy-6-18F-ﬂuorophenylalanine (F-Dopa), an indicator of
presynaptic dopaminergic function. In this way, clinical PD characteris-
tics can be ‘neurochemically’ investigated (Loane and Politis, 2011;
Vingerhoets et al., 1997). Dopaminergic deﬁcit, e.g., has been repeatedly
associated with hypokinesia and rigidity (Benamer et al., 2003; Eggers
et al., 2014; Spiegel et al., 2007). Such association, however, is less evi-
dent for tremor, another cardinal PD feature (Benamer et al., 2003;
Isaias et al., 2007; Spiegel et al., 2007; Martin et al., 2008; Eggers et al.,
2014). This generated the idea that PD tremor may not only depend
on depletion of striatal dopamine but that deﬁcit of other monoaminer-
gic neurotransmitters such as serotonin (Doder et al., 2003) or
noradrenalin (Isaias et al., 2012)may play a role. Alternatively, dopami-
nergic deﬁcit in speciﬁc regions of the basal ganglia regions (pallidum)B44), UniversityMedical Center
gen, The Netherlands.
), a.van.der.hoorn@umcg.nl
b.m.de.jong@umcg.nl (B.M. de
. This is an open access article underhas been suggested to generate the tremor by functional interaction of
this site with cerebello-thalamic circuitry (Helmich et al., 2011).
The results from these studies were based on various analysis
methods, patient numbers and disease duration. Here, we investigated
the association between striatum F-Dopa uptake and the main PD
symptoms tremor and hypokinesia-rigidity in a large patient popula-
tion, scanned at a relative early stage of disease and employing a straight
forward transparent analysis method. We hypothesized to ﬁnd a corre-
lation between dopaminergic depletion and contralateral dominance of
hypokinesia-rigidity, while such correlation was not expected for trem-
or. We further assessed the possible relation between striatum F-Dopa
uptake and Freezing of gait (FOG) (Giladi et al., 2001). Pathophysiology
underlying this disabling symptom remains unclear, but improvement
by levodopa supports the relation with a dopaminergic state (Bartels
et al., 2006).
2. Patients and methods
2.1. Study population
PD patients were retrospectively identiﬁed from the Neurology De-
partment, University Medical Center Groningen. Over an 18 month pe-
riod, we included a consecutive sample of 370 patients who visited our
department with either a new or previously established diagnosis of id-
iopathic PD. Diagnosis was made by a movement disorders neurologistthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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formed. Three patients were excluded due to change of diagnosis and
one because the patient ﬁle was incomplete. This resulted in
366 patients classiﬁed as PD (57% male, age of ﬁrst symptoms
58.7 years ± 11.8; mean ± SD). F-Dopa PET was performed in 129 pa-
tients at 3.2 ± 3.9 years disease duration. This scan was made to gain
further support for the diagnosis PD. Within this group, either tremor
(N = 60) or hypokinesia-rigidity (N = 42) was the onset symptom,
while for the remaining 27 patients another or unknown onset symp-
tom was reported. The Uniﬁed Parkinson's Disease Rating Scale
(UPDRS) sub-score was described in 79 of these 129 patients (Fig. 1).
This enabled correlating type of onset symptom and F-Dopa values in
102 patients, while for 79 patients possible correlation between UPDRS
sub-scores for either tremor or hypokinesia-rigidity and F-Dopa values
could be assessed. Ethical committee approval was not required as this
study concerned retrospective analysis of restricted parameters.
2.2. Data retrieval
General patient characteristics, according to standard medical care,
were documented by the treating neurologist in the medical ﬁle.
These characteristics were retrieved including year of onset and year
of PD diagnosis. Onset of PD was deﬁned as the ﬁrst PD-attributed
sign noticed by the patient, a relative or care provider. Onset symptom
was classiﬁed as tremor, hypokinesia-rigidity or another/unknown
onset type. Likewise we assessed whether experienced FOG wasFig. 1. The ﬂow diagram showed thregistered in the patient history. FOG was assessed at each clinical
visit by asking whether a patient feels their feet getting glued to the
ﬂoor while either walking, turning or trying to initiate walking (Giladi
et al., 2000). If seen during examination (generally performed in on-
state without medication stop), FOG was also recorded. We acknowl-
edge that this documentation of FOG does not concern a highly speciﬁc
assessment. We further retrieved the patients' ﬁrst recorded UPDRS
part III which, in general, was also assessed in on-state. Using items 20
and 21 of the UPDRS motor score (hands and feet), a sum rest tremor
sub-score was created for the right and left side separately. Similarly, a
sum hypokinesia-rigidity score (items 22–26) was obtained for each
side. A ratio with each maximum UPDRS sub-score, subsequently
expressed as percentage, was used to facilitate the comparison between
rigidity and tremor. For rigidity, the maximum sub-score was 24 points
while it was maximally 8 points for tremor, thus allowing between-
group comparisons.
By reviewing radiology reports of clinically obtained PET scans, we
extracted F-Dopa uptake values for standard regions of interest in puta-
men and caudate nucleus, both contra- and ipsilateral to the dominant
symptom side. Striatum F-Dopa uptakewas expressed as a ratio relative
to occipital reference tissue.
2.3. Statistical analysis
General characteristics of patients with and without a F-Dopa PET
were compared using a Mann–Whitney U-test for continuous non-e distributions of PD patients.
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type, ﬁrst obtained UPDRS tremor and UPDRS hypokinesia-rigidity sub-
scores were correlated with F-Dopa uptake values by Spearman
correlations.
Thirty patients with F-Dopa PET experienced FOG (‘FOG group’).
As basic characteristics did not match with the 98 non-FOG patients
(nFOG), the FOG group was matched to an equally large nFOG sample
(N= 30) concerning age, clinical follow-up duration and age at F-Dopa
PET (see also Fig. 1). This was carried out by one investigator (A.H)
without knowledge of F-Dopa results at the time of this assessment.
Differences between groups were analyzed with the T-test or Mann–
Whitney U-test, depending on normality. Two-tailed p b 0.05 was con-
sidered signiﬁcant for all comparisons.
3. Results
3.1. General characteristics
UPDRSwas assessed 3.0±3.8 years (mean±SD) after disease onset
while F-Dopa PET was assessed 3.2 ± 3.9 years after disease onset. The
dominant symptom side corresponded with reduced F-Dopa uptake in
particularly the contralateral striatum (caudate 2.21 ± 0.29 and puta-
men 1.81 ± 0.24 versus ipsilateral caudate 2.29 ± 0.29 and putamen
1.94 ± 0.24). General characteristics including age, sex, and onset type
symptom were similar for patients who either received or not received
F-Dopa PET, as well as for patients with or without a recorded initial
UPDRS.
3.2. F-Dopa PET related to tremor and hypokinesia-rigidity
For an initial assessment of F-Dopa characteristics and onset parkin-
sonian symptoms, we selected patients with PET measurements for
which the onset symptom tremor (N = 60) or hypokinesia-rigidity
(N = 42) was reported, thus allowing a global comparison between
the two groups. F-Dopa uptake values in caudate and putamen of each
hemisphere were used to assess a correlation with the lateralized
onset symptoms in these groups. The hypokinesia-rigidity group, com-
pared to the tremor group, showed reduced F-Dopa uptake in both pu-
tamen and caudate nucleus without, however, reaching statistical
signiﬁcance (putamen left 1.83 ± 0.25 and 1.96 ± 0.29, putamen right
1.85 ± 0.31 and 1.90 ± 0.26, caudate left 2.22 ± 0.29 and 2.32 ±
0.29, caudate right 2.17 ± 0.31 and 2.28 ± 0.28 for hypokinesia-
rigidity and tremor, respectively). The main analysis of this study wasFig. 2. Dominant symptom side related to contralateral F-Dopa putamen uptake. The UPDRS
r =−0.002, p = 0.987** (B) are correlated with the contralateral dopamine uptake for the m
sub-score. F-Dopa putamen uptake is expressed as the ratio relative to the occipital reference tsubsequently performed using the ﬁrst obtained UPDRS score, thus en-
abling the assessment of a relation between F-Dopa values and the se-
verity of hypokinesia-rigidity and tremor in 79 PD patients. Left-sided
UPDRS scores for hypokinesia-rigidity showed a negative correlation
with F-Dopa PET dopamine uptake in the entire contralateral striatum
(putamen r =−0.343; p = 0.002; caudate r =−0.221; p = 0.049).
The right-sided UPDRS signiﬁcantly correlated with reduced F-Dopa
uptake in the left putamen (r = −0.286; p = 0.010) while such
correlation remained sub-threshold for the left caudate nucleus
(r = −0.186; p = 0.093). No relation was seen between UPDRS
hypokinesia-rigidity scores and ipsilateral F-Dopa uptake. For the
UPDRS tremor score, no signiﬁcant correlationswere seenwith reduced
F-Dopa uptake, neither in the contralateral nor in the ipsilateral stria-
tum. The relation between the UPDRS sub-scores for each of the two
cardinal PD symptoms and F-Dopa uptake is shown in Fig. 2.
3.3. F-Dopa PET related to freezing of gait
FOG patients had a follow-up duration of 8.1 ± 4.1 years, matching
the selected nFOG patients (7.4 ± 4.0 years). The ﬁrst record of FOG
was 6.7 ± 3.9 years after the ﬁrst visit, thus 2.7 ± 3.7 years after the
F-Dopa PET. The (ﬁrst recorded) UPDRS hypokinesia-rigidity items of
both the left and right side were similar in the FOG and nFOG-groups,
no signiﬁcant difference was seen. Comparing the obtained PET mea-
surement in the FOG-group with the matched nFOG revealed signiﬁ-
cantly lower F-Dopa uptake (mean ± SD) in the putamen of the right
hemisphere (1.72 ± 0.29 versus nFOG 1.93 ± 0.29; p= 0.005). A sim-
ilar group difference was seen for the left putamen without, however,
reaching formal statistical signiﬁcance (p = 0.052). Neither the right
nor the left caudate nucleus showed a signiﬁcant between-group differ-
ence. Within each group, F-Dopa uptake did not signiﬁcantly differ be-
tween the opposite striatum nuclei (FOG caudate p = 0.444, putamen
p= 0.062; nFOG caudate p= 0.206 and putamen p= 0.627).
4. Discussion
Investigating the association between striatum F-Dopa and the PD
symptoms tremor and hypokinesia-rigidity, the registered onset symp-
tom hypokinesia-rigidity and ﬁrst taken UPDRS scores of this symptom
revealed a clear correlation with reduced dopamine uptake in the con-
tralateral striatum. In the equally large UPDRS group with quantitative
data on tremor, no such correlation was seen. This underscores the dif-
ference in pathomechanisms underlying these symptoms, suggestinghypokinesia-rigidity values, r =−0.187, p = 0.097* (A) and the UPDRS tremor values,
ost affected side. UPDRS value is the patient UPDRS sub-score relative to the maximum
issue. *Pearson correlation, **Spearman's correlation.
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toms while another causal factor appears to generate PD tremor. Our
retrospective PD study did not include healthy control subjects. Never-
theless, the ﬁnding that F-Dopa putamen uptake was lower than the
caudate uptake, in both the hypokinesia-rigidity and tremor group, un-
derscores the classical uptake proﬁle seen in PD (Leenders et al., 1990;
Eshuis et al., 2009); healthy subjects are characterized by an equal
putamen-caudate distribution of F-Dopa uptake.While we are reluctant
to infer speciﬁc differences in pathomechanisms underlying these two
cardinal PD symptoms, our study provides solid arguments to maintain
searching for such differences.
The observed correlation between hypokinesia-rigidity and F-Dopa
uptake values is consistent with existing literature. The dissociation be-
tween hypokinesia-rigidity and tremor, without a speciﬁc dopamine
deﬁcit related to the latter, is ﬁrmly based on the large patient number
in our study. Previous studies on the tremor-dopamine relation were
contradicting, in which low patient numbers may have sometimes
played a role (Benamer et al., 2003; Eggers et al., 2011; Isaias et al.,
2007; Spiegel et al., 2007). Other reasons may have been the use of ei-
ther 5-Dopa PET or FP-CIT SPECT, varying strategies of data analysis or
disease stage. E.g., visual inspection of FP-CIT images has revealed less
caudal striatum uptake in PD patients with hypokinesia-rigidity than
in tremor (Eggers et al., 2011) while a direct comparison between F-
Dopa uptake in such PD groups showed rostral uptake reduction in
hypokinesia-rigidity (Eggers et al., 2014). Analysis of FP-CIT imaging
data, including assessment of pallidum uptake additional to striatum
measurements, and introducing a ratio betweenmost and least affected
side pointed at a correlation between tremor severity and reduced con-
tralateral pallidum uptake (Helmich et al., 2011). In this respect, our
large study with robust classical methods complements previous stud-
ies, allowing a convincing conclusion concerning the absence of a rela-
tion between the severity of tremor and striatum dopamine uptake.
We had no data on pallidum F-Dopa uptake available, so we could not
further explore the proposed link between pallidum dopaminergic def-
icit and cerebello-thalamic circuitry as a causal factor in PD tremor
(Helmich et al., 2011).
Future studies combining (i) imagingmodalities aimed at functional
networks such as FDG-PET or resting-state fMRI with (ii) speciﬁc
monaminergic PET tracers (Loane and Politis, 2011) appear to be
most promising in getting the full picture on the differences in
pathomechanisms underlying PD tremor and hypokinesia-rigidity. In
such studies, attention needs to be given to disease duration because
progression of PD over time particularly inﬂicts more hypokinesia-
rigidity while tremor may stay rather stable (Eggers et al., 2012). In
this respect, it may be noticed that the mean interval of 3.2 years be-
tween ﬁrst recalled symptom and F-Dopa PET was relatively short in
our study. This issue is particularly urgent because the ongoing decrease
of F-Dopa uptake during disease progression is not evenly distributed
within the basal ganglia. The early stage assessment in our study is
due to the retrospective nature of our study; patients were scanned
for diagnostic reasons while their follow-up provided the opportunity
to exclude possible patients who turned out not to suffer from PD. On
the other hand, retrospective data analysis implied that were not able
to get a UPDRS score of all 129 patients that underwent F-Dopa PET. Al-
though this might limit the interpretation of the results, the remaining
group of 79 patients is still large enough to draw conclusions from. Fur-
thermore, the basis characteristics did not differ between patients that
did and did not receive a F-Dopa PET scan.
FOG showed bilaterally reduced putamen uptake, which only
reached statistical signiﬁcance in the right hemisphere. F-Dopa deple-
tion in FOG compared to nFOG patients has been reported before
(Giladi et al., 2001). Although a levodopa-independent state may play
a role in FOG, approaching FOG as a dopamine-responsive symptom is
generally advised (Nonnekes et al., 2015). In our results, the deﬁcit ap-
pears to be localized in the putamen more than the caudate nucleus.
Using voxel-based statistical parametric analysis, which includednormalization steps in global uptake, a relation between FOG and par-
ticularly right hemisphere impairment has previously been suggested
(Giladi et al., 2000; Bartels et al., 2006; van der Hoorn et al., 2014).
The present research only hints at such asymmetry without statistically
support. It should be considered, in this respect, that FOG emerged as a
relative late symptom during follow-up of the patients in our study,
while the (ﬁrst recorded) UPDRS and F-Dopa uptake were assessed at
relative early disease stages, indeed preceding the symptom. One
might speculate that asymmetry in F-Dopa uptake was an early marker
of this symptomwhich could have reached statistical signiﬁcance at the
stage of overt FOG.
5. Conclusion
Our large patient group demonstrated that increased severity of
hypokinesia-rigidity symptoms correlated with reduced dopamine up-
take values measured with F-Dopa PET. For UPDRS tremor symptoms
no such correlation was found. Furthermore, freezing of gait correlated
with lower F-Dopa uptake in the putamen.
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